The SCCT developed and published a guidance document in the Journal of Cardiovascular Computed Tomography on when to use cardiac CT during the pandemic. This suggests that coronary CTA may be used in carefully selected patients with elevated cardiac enzymes, symptoms of ACS and an inconclusive ECG to exclude obstructive CAD. In addition, this document states that the use of coronary CTA should only be considered when diagnostic quality imaging can be achieved.
“This is important because not all patients with elevated enzymes are going to be good candidates for coronary CTA, so we have to be selective,†Blankstein said.
Similar recommendations were made in a statement by the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions and the American College of Emergency Physicians. Guidance from the European Society of Cardiology states that coronary CTA is preferred in patients with acute chest pain and suspected obstructive CAD.
|